Literature DB >> 3829380

Estimating fat in feces by near-infrared reflectance spectroscopy.

G Koumantakis, F J Radcliff.   

Abstract

We describe use of near-infrared reflectance spectroscopy (NIRRS) to estimate the amount of fat in feces, for diagnosis of steatorrhea. After sample homogenization, the spectrum of the fecal homogenate is scanned over the near-infrared region. Assay of 94 samples of feces having a known concentration of fat showed the appropriate wavelengths for the NIRRS procedure to be 1734, 1778, 1818, 2270, and 2310 nm. The reflectance output of 47 fecal samples subsequently measured at these wavelengths was used to compute the reflectance scaling factors (F values) by the instrument's microprocessor. Assay of fat content in a further 124 fecal samples, by both hydrolysis/titration (J Biol Chem 1949;177:347) and the NIRRS procedure at the wavelengths and corresponding F values previously determined, gave results that correlated highly satisfactorily. However, the NIRRS procedure demonstrated much better precision.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829380

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Near-infrared spectrometry analysis of fat, neutral sterols, bile acids, and short-chain fatty acids in the feces of patients with pancreatic maldigestion and malabsorption.

Authors:  T Nakamura; T Takeuchi; A Terada; Y Tando; T Suda
Journal:  Int J Pancreatol       Date:  1998-04

2.  Clinical validation of an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy through a prospective interventional study in paediatric patients with Cystic Fibrosis.

Authors:  Joaquim Calvo-Lerma; Jessie Hulst; Mieke Boon; Carla Colombo; Etna Masip; Mar Ruperto; Victoria Fornés-Ferrer; Els van der Wiel; Ine Claes; Maria Garriga; Maria Roca; Paula Crespo-Escobar; Anna Bulfamante; Sandra Woodcock; Sandra Martínez-Barona; Ana Andrés; Kris de Boeck; Carmen Ribes-Koninckx
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.